Ten years of experience with peptide nucleic acid fluorescent in situ hybridization in the clinical microbiology laboratory

Clinical Microbiology Newsletter

Volumn 35, Issue 10, 2013, Pages 79-83

  Morgan, Margie A ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ECHINOCANDIN; FLUCONAZOLE; PEPTIDE NUCLEIC ACID;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL STEWARDSHIP; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM CONTAMINATION; BIOTECHNOLOGY; BLOOD CULTURE; CANDIDIASIS; CLINICAL LABORATORY; COST EFFECTIVENESS ANALYSIS; DRUG DOSE ESCALATION; FLUORESCENCE IN SITU HYBRIDIZATION; HOSPITAL COST; HOSPITAL INFECTION; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; MICROBIAL IDENTIFICATION; MICROBIOLOGY; NONHUMAN; PATIENT CARE; PERFORMANCE; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS;

EID: 84877139397     PISSN: 01964399     EISSN: 18734391     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2013.04.002     Document Type: Article

References (15)

1. Forrest G.N., et al. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob. Agents Chemother 2008, 52:3558-3563.
2. Kumar A., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med 2006, 34:1589-1596.
3. Oliveira K., et al. Direct identification of Staphylococcus aureus from positive blood culture bottles. J. Clin. Microbiol. 2003, 41889-41891.
4. Forrest G., et al. Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. J. Antimicrob. Chemother 2006, 58:154-158.
5. Bauer K.A.G., et al. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant blood culture test in patients with bacteremia. Clin. Infect. Dis 2010, 51:1074-1080.
6. Zwang O., Albert R.K. Analysis of strategies to improve cost effectiveness of blood cultures. J. Hosp. Med 2006, 1:272-276.
7. Gamage, D.C. et al. 2011. Significant decreases in mortality and hospital costs after laboratory testing with PNA FISH, poster D-1302b. Presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL.
8. Kang C.I., et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin. Infect. Dis 2003, 37:745-751.
9. Della-Latta P., et al. Idenfication of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa in blood cultures: a multicenter performance evaluation of a three-color peptide nucleic acid fluorescence in situ hybridization. J. Clin. Microbiol 2011, 49:2259-2261.
10. AdvanDX. 2012. GNR Traffic Light™ PNA FISH package insert PN1718.Rev.F. AdvanDX, Woburn, MA.
11. Mermel L.A., et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: Update by the Infectious Diseases Society of America. IDSA guidelines. Clin Infect Dis 2009, 48:503-535.
12. Forrest G., et al. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J. Clin. Microbiol 2006, 44:3381-3383.
13. AdvanDX. 2012. Staphylococcus QuickFISH™ package insert PN1878. Rev.D. AdvanDX, Woburn, MA.
14. Deck M.K., et al. Multicenter evaluation of the Staphylococcus QuickFISH method from simultaneous identification of Staphylococcus aureus and coagulase negative Staphylococcus directly from blood culture bottles in less than 30 minutes. J. Clin. Microbiol 2012, 50:1994-1998.
15. Carretto E., et al. Comparison of the Staphylococcus QuickFISH BC test with the tube coagulase test performed on positive blood cultures for evaluation and application in a clinical routine setting. J. Clin. Microbiol 2013, 51:131-135.